Literature DB >> 10403746

Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.

A Pascoe1, P Kerlin, C Steadman, A Clouston, D Jones, L Powell, E Jazwinska, S Lynch, R Strong.   

Abstract

BACKGROUND: Following orthotopic liver transplantation (OLT) histological examination of explant livers from patients with alcoholic liver disease (ALD) sometimes shows extensive iron deposits in a distribution suggestive of homozygous haemochromatosis. AIMS: To use haemochromatosis gene (HFE) assays to distinguish between ALD with notable siderosis and hereditary haemochromatosis. To evaluate the possible influence of spur cell haemolytic anaemia on hepatic iron loading. PATIENTS: Thirty seven patients with ALD were abstinent for at least six months prior to OLT. Twenty three patients had transferrin saturations greater than 55%, 16 also had increased serum ferritin (>350 micrograms/l). Eight of 37 (22%) explant livers had grade 3 or 4 hepatic iron deposition, predominantly in hepatocytes. Of these, four had a hepatic iron index greater than 1. 9 and most seemed to have spur cell haemolytic anaemia.
METHODS: Mutation analysis for C282Y and H63D mutations was performed on DNA extracts from peripheral blood or explant liver. Spur cell haemolytic anaemia was diagnosed when the haemoglobin was 105 g/l in the presence of notable acanthocytosis.
RESULTS: None of the eight patients with grade 3 or 4 hepatic iron had evidence of the C282Y mutation. Two of the eight were heterozygous for H63D. None of the remaining 28 patients tested showed homozygous HFE mutations. Spur cell anaemia was present in six of the eight patients with heavy iron deposition and only one of the remaining patients.
CONCLUSIONS: The HFE mutation was not present in these patients with advanced ALD and heavy iron loading. Spur cell haemolytic anaemia provides an alternative potential mechanism for the heavy iron loading.

Entities:  

Mesh:

Year:  1999        PMID: 10403746      PMCID: PMC1727602          DOI: 10.1136/gut.45.2.301

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  SPUR-CELL ANEMIA: HEMOLYTIC ANEMIA WITH RED CELLS RESEMBLING ACANTHOCYTES IN ALCOHOLIC CIRRHOSIS.

Authors:  J A SMITH; E T LONERGAN; K STERLING
Journal:  N Engl J Med       Date:  1964-08-20       Impact factor: 91.245

2.  The hemochromatosis 845 G-->A and 187 C-->G mutations: prevalence in non-Caucasian populations.

Authors:  L M Cullen; X Gao; S Easteal; E C Jazwinska
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.

Authors:  M Simon; M Bourel; B Genetet; R Fauchet
Journal:  N Engl J Med       Date:  1977-11-10       Impact factor: 91.245

4.  Role of the spleen in membrane conditioning and hemolysis of spur cells in liver disease.

Authors:  R A Cooper; D B Kimball; J R Durocher
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

5.  Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis.

Authors:  R W Chapman; M Y Morgan; M Laulicht; A V Hoffbrand; S Sherlock
Journal:  Dig Dis Sci       Date:  1982-10       Impact factor: 3.199

6.  Measurement of liver-iron concentration in needle-biopsy specimens.

Authors:  M Barry; S Sherlock
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

7.  Spur-shaped erythrocytes in Laennec's cirrhosis.

Authors:  R Silber; E Amorosi; J Lhowe; H J Kayden
Journal:  N Engl J Med       Date:  1966-09-22       Impact factor: 91.245

8.  Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.

Authors:  C Niederau; R Fischer; A Sonnenberg; W Stremmel; H J Trampisch; G Strohmeyer
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

9.  Hereditary hemochromatosis. Phenotypic expression of the disease.

Authors:  G E Cartwright; C Q Edwards; K Kravitz; M Skolnick; D B Amos; A Johnson; L Buskjaer
Journal:  N Engl J Med       Date:  1979-07-26       Impact factor: 91.245

10.  Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.

Authors:  M L Bassett; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

View more
  7 in total

1.  Normal iron metabolism and the pathophysiology of iron overload disorders.

Authors:  Chiang W Siah; John Ombiga; Leon A Adams; Debbie Trinder; John K Olynyk
Journal:  Clin Biochem Rev       Date:  2006-02

Review 2.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 3.  Role of iron in hepatic fibrosis: one piece in the puzzle.

Authors:  Marie-A Philippe; Richard-G Ruddell; Grant-A Ramm
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

4.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

Review 5.  The pathophysiology of thrombocytopenia in chronic liver disease.

Authors:  Oscar Mitchell; David M Feldman; Marla Diakow; Samuel H Sigal
Journal:  Hepat Med       Date:  2016-04-15

6.  Protective Effect of Aplysin Supplementation on Intestinal Permeability and Microbiota in Rats Treated with Ethanol and Iron.

Authors:  Yan Ma; Ruiying Li; Ying Liu; Man Liu; Hui Liang
Journal:  Nutrients       Date:  2018-05-27       Impact factor: 5.717

7.  Analyzing lipids in the liver & in the red blood cell membrane in liver diseases.

Authors:  C E Eapen; Banumathi Ramakrishna; K A Balasubramanian
Journal:  Indian J Med Res       Date:  2018-04       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.